Cargando…
Differences in self-monitored, blood glucose test strip utilization by therapy for type 2 diabetes mellitus
AIMS: To determine whether blood glucose test strip (BGTS) utilization in patients with type 2 diabetes (T2D) is associated with the type of diabetes therapy, classified according to hypoglycemic risk. METHODS: A retrospective, longitudinal (2006–2012) study of Canadian private drug plans (PDP) and...
Autores principales: | Tavares, Ruben, Duclos, Marc, Brabant, Marie-Josée, Checchin, Daniella, Bosnic, Nevzeta, Turvey, Katherine, Terres, Jorge Alfonso Ross |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877426/ https://www.ncbi.nlm.nih.gov/pubmed/26972690 http://dx.doi.org/10.1007/s00592-015-0823-z |
Ejemplares similares
-
Nanoplasmonic Strip Test for Salivary Glucose Monitoring
por: Torné-Morató, Helena, et al.
Publicado: (2021) -
Rosiglitazone use and associated adverse event rates in Canada: an updated analysis
por: Iczkovitz, Sandra, et al.
Publicado: (2015) -
The aging Canadian population and hospitalizations for acute myocardial infarction: projection to 2020
por: Rawson, Nigel SB, et al.
Publicado: (2012) -
The methodology of glucose monitoring in type 2 diabetes mellitus
por: GRIBOVSCHI, MIHAELA
Publicado: (2013) -
A longitudinal study into the new and long-term use of self-monitoring blood glucose strips in the UK
por: Morgan, C. L., et al.
Publicado: (2010)